93 7325 Pill - beige capsule/oblong, 8mm
Pill with imprint 93 7325 is Beige, Capsule/Oblong and has been identified as Trandolapril 1 mg. It is supplied by Teva Pharmaceuticals USA.
Trandolapril is used in the treatment of Diabetic Kidney Disease; Left Ventricular Dysfunction; Heart Attack; Heart Failure; High Blood Pressure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Trandolapril 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7325
Trandolapril
- Imprint
- 93 7325
- Strength
- 1 mg
- Color
- Beige
- Size
- 8.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
ferric oxide yellow,
lactose anhydrous,
povidone k30,
corn starch,
sodium stearyl fumarate,
FD&C Blue No. 2,
indigotindisulfonate sodium,
aluminum oxide,
FD&C Red No. 40,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-7325 (Discontinued) | Teva Pharmaceuticals USA, Inc. |
| 42291-0837 | AvKare, Inc. |
More about trandolapril
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: Angiotensin Converting Enzyme Inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
